Arthroscopic Implantation of a Cell-Free Bilayer Scaffold for the Treatment of Knee Chondral Lesions: A 2-Year Prospective Study
2024

Knee Cartilage Repair with a Cell-Free Scaffold

Sample size: 31 publication 10 minutes Evidence: moderate

Author Information

Author(s): Rimtautas Gudas, Mantas Staškūnas, Justinas Mačiulaitis, Emilė Gudaitė, Ieva Aleknaite-Dambrauskiene

Primary Institution: Hospital of Lithuanian University of Health Sciences, Kaunas Clinics

Hypothesis

The new MaioRegen Chondro+ scaffold is as safe and effective as its predecessor for treating knee chondral lesions.

Conclusion

MaioRegen Chondro+ is a safe and effective device for the treatment of knee chondral lesions, enabling a significant clinical improvement for at least 2 years.

Supporting Evidence

  • IKDC scores improved significantly at 6, 12, and 24 months after treatment.
  • Tegner scores reached preinjury levels by 12 months post-surgery.
  • MOCART scores showed significant improvement at 12 months.
  • No adverse events were reported during the study.
  • Results were consistent across different lesion sites and etiologies.

Takeaway

Doctors used a special scaffold to help fix damaged cartilage in people's knees, and it worked really well for at least two years.

Methodology

Thirty-one patients with knee chondral lesions were treated with a cell-free bilayer scaffold and evaluated for 2 years using various clinical scores.

Potential Biases

The study was conducted by the investigators, which may introduce bias.

Limitations

The study lacked a control group and had a relatively small sample size.

Participant Demographics

Mean age was 38.9 years, with 4 females and 27 males.

Statistical Information

P-Value

<0.001

Confidence Interval

95% CI: 16.9-22.2

Statistical Significance

p<0.001

Digital Object Identifier (DOI)

10.1177/19476035241232061

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication